Cancer

Melanoma: A Challenge Melanoma, a highly malignant type of skin cancer, is a significant health concern globally, with a median survival of 6 to 10 months. Researchers are actively investigating the cell signaling mechanisms that can affect tumour growth. Recently, the Institute of Cancer Research, London, reported on a significant scientific discovery. Researchers grew cells...

Melanoma brain metastasis (MBM) is found in 30–40% of patients with advanced melanoma. While treatment options are accessible, MBM remains a challenge to treat effectively. Around 30-40% of patients with advanced melanoma present with melanoma brain metastases (MBM) at diagnosis, with a higher percentage of patients exhibiting MBM at the time of death in autopsy....

Patients with multiple comorbidities in addition to melanoma may be less likely to receive appropriate treatment than patients without comorbidities. Clinicians and health systems are encouraged to address these inequalities in melanoma treatment. Disparities in the treatment of patients with melanoma exist in the United States and can have a negative impact on patient outcomes....

Age-related disparities exist in patients with advanced melanoma regarding overall survival. One study addressed the limited data on the use of immune checkpoint inhibitors (ICIs) in different age groups and their effect on survival rates. Immune checkpoint inhibitors (ICIs) changed the landscape of melanoma treatment, improving the overall survival (OS) of affected patients. Studies have...

Detecting melanoma early in patients is crucial for ensuring positive outcomes. A cross-sectional audit study explains the importance of increasing healthcare access and educating primary care physicians on diagnostic techniques. Melanoma is one of the most common cancers with a generally good prognosis if caught early. However, the late detection of melanoma could lead to...

Patients with skin of color (SOC) face disproportionately high rates of morbidity and mortality from melanoma. Increasing the awareness of disparities in melanoma recognition and improving diagnostic strategies are key to improving the outcomes of melanoma. Melanoma is a relatively common skin cancer that affects all groups of people in the United States. However, the...

Multiple Myeloma Status Quo Over 30,000 Americans are diagnosed with multiple myeloma each year. And more than 12,500 Americans pass away due to multiple myeloma annually. Multiple myeloma is a cancer of plasma cells. With multiple myeloma, the bone marrow consists of excess plasma cells associated with monoclonal protein in the blood and/or urine. Clinical...

Lesbian, gay, and bisexual (LGB) adults differ from heterosexual adults on several health indicators, according to a study published in the National Health Statistics Reports, a publication from the U.S. Centers for Disease Control and Prevention. Kevin C. Heslin, Ph.D., and Johanna M. Alfier, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland,...

In the general population, Black patients tend to experience more severe disease from COVID-19 than white patients. However, few studies seek to address whether Black patients with cancer experience worse outcomes from COVID-19 than white patients with cancer. Structural racism carried out through sociodemographic factors, such as underinsurance and disproportionate access to health care, may...